(Q37983683)

26 August 2017

Sex-related differences in patients' responses to heart failure therapy (English)

1 reference

26 August 2017

0 references

3

Ilan Goldenberg

1 reference

26 August 2017

Alon Barsheshet

1

1 reference

26 August 2017

Andrew Brenyo

series ordinal

2

1 reference

26 August 2017

Arthur J Moss

series ordinal

4

1 reference

26 August 2017

language of work or name

English

0 references

publication date

14 February 2012

1 reference

Nature Reviews Cardiology

26 August 2017

1 reference

26 August 2017

9

1 reference

26 August 2017

4

1 reference

26 August 2017

234-242

1 reference

Heart disease and stroke statistics--2011 update: a report from the American Heart Association

26 August 2017

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.10

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.10

Long-Term Trends in the Incidence of and Survival with Heart Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.10

Effect of bundle branch block patterns on mortality in hospitalized patients with heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.10

Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.10

The progression from hypertension to congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.10

Metoprolol CR/XL in female patients with heart failure: analysis of the experience in Metoprolol Extended-Release Randomized Intervention Trial in Heart Failure (MERIT-HF).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.10

Sex differences in the prognosis of congestive heart failure: results from the Cardiac Insufficiency Bisoprolol Study (CIBIS II).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.10

Gender differences in advanced heart failure: insights from the BEST study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.10

Relation between gender, etiology and survival in patients with symptomatic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.10

Heart failure in women: a need for prospective data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.10

The effects of biological sex and diet on the development of heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.10

Influence of gender on the response to hemodynamic overload after myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.10

Gender differences in cardiac function during early remodeling after acute myocardial infarction in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.10

A standardized definition of ischemic cardiomyopathy for use in clinical research

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.10

Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.10

Gender, age, and heart failure with preserved left ventricular systolic function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.10

Acute vascular effects of estrogen in postmenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.10

Randomized, double-blind, placebo-controlled study on effects of raloxifene and hormone replacement therapy on plasma no concentrations, endothelin-1 levels, and endothelium-dependent vasodilation in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.10

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.10

Effect of carvedilol on survival in severe chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.10

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.10

Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.10

Efficacy of angiotensin-converting enzyme inhibitors and beta-blockers in the management of left ventricular systolic dysfunction according to race, gender, and diabetic status: a meta-analysis of major clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.10

Mortality and morbidity reduction with Candesartan in patients with chronic heart failure and left ventricular systolic dysfunction: results of the CHARM low-left ventricular ejection fraction trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.10

A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.10

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.10

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.10

Eplerenone in patients with systolic heart failure and mild symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.10

Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.10

Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.10

Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.10

Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.10

Clinical course and implantable cardioverter defibrillator therapy in postinfarction women with severe left ventricular dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.10

Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.10

Gender differences in clinical outcome and primary prevention defibrillator benefit in patients with severe left ventricular dysfunction: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.10

Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.10

The effect of cardiac resynchronization on morbidity and mortality in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.10

Cardiac-resynchronization therapy for the prevention of heart-failure events.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.10

Cardiac resynchronization induces major structural and functional reverse remodeling in patients with New York Heart Association class I/II heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.10

Cardiac-resynchronization therapy for mild-to-moderate heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.10

Cardiac resynchronization therapy is more effective in women than in men: the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.10

Effectiveness of Cardiac Resynchronization Therapy by QRS Morphology in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.10

Comparison of Time Course of Response to Cardiac Resynchronization Therapy in Patients With Ischemic Versus Nonischemic Cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.10

The effects of aetiology on outcome in patients treated with cardiac resynchronization therapy in the CARE-HF trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.10

Prognostic significance of corrected QT and corrected JT interval for incident coronary heart disease in a general population sample stratified by presence or absence of wide QRS complex: the ARIC Study with 13 years of follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.10

Diabetic cardiomyopathy revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.10

ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 G

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.10

Cardiac resynchronization in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.10

Trends in Heart Failure Incidence and Survival in a Community-Based Population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.10

Gender differences in survival in advanced heart failure. Insights from the FIRST study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.10

Comparison of clinical findings in idiopathic dilated cardiomyopathy in women versus men. The Italian Multicenter Cardiomyopathy Study Group (SPIC)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.10

31 March 2020

Heart failure in women

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.10

Etiology and response to drug treatment in heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.10

Spectrum and outcome of congestive heart failure in a hospitalized population

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.10

Clinical determinants of mortality in patients with angiographically diagnosed ischemic or nonischemic cardiomyopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.10

Response to preventive cardiac resynchronization therapy in patients with ischaemic and nonischaemic cardiomyopathy in MADIT-CRT

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.10

Age-related changes in blood pressure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.10

Association between increased estrogen status and increased fibrinolytic potential in the Framingham Offspring Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.10

2009 Focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Deve

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.10

The effect of digoxin on mortality and morbidity in patients with heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.10

Sex-based differences in the effect of digoxin for the treatment of heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.10

A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.10

Results of the Predictors of Response to CRT (PROSPECT) trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.10

Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systo

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.10

Usefulness of baseline electrocardiographic QRS complex pattern to predict response to cardiac resynchronization

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.10

Sustained reverse left ventricular structural remodeling with cardiac resynchronization at one year is a function of etiology: quantitative Doppler echocardiographic evidence from the Multicenter InSync Randomized Clinical Evaluation (MIRACLE)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.10

Postmenopausal hormonal replacement decreases plasma levels of endothelin-1

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22330611

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The Miracle of Microfinance? Evidence from a Randomized Evaluation

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22330611

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NRCARDIO.2012.10

1 reference

26 August 2017

1 reference